The effect of GLP-1R agonists liraglutide and exendin-4 was examined in vitro on LOVO, CA-77, MCF-7, MDA-MB-231, KPL-1, MB-468, 4TI, BT483, ZR751, LNCap, PC3, ALVA-41, DU145, LNCap, PANC-1, MiaPaCa-2, PANC, CT26, SKOV3, OVCAR3, OVCAR4, A2780, and ES-2 cell lines that are expressed in several cancers including colorectal, pancreatic, thyroid, breast, prostate, ovarian, and colon (Table 1)
But how accurate are these tests, and are the results useful
Did I specify follow-up instructions
In rare cases, it may lead to low blood pressure or an increased heart rate
Retatrutide's ~6-day half-life means that a 5-day dosing interval would administer the next dose before the drug has reached one half-life resulting in higher trough levels and faster accumulation to steady state